Carisoprodol
- Product NDC
- 62135-241
- 11-digit product format
- 621350241
- Labeler code
- 62135
- Product ID
- 62135-241_458c539a-5c3d-0ecd-e063-6294a90a2de7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA040245
- Marketing category
- ANDA
- Marketing start
- 2019-08-08
- Substance
- CARISOPRODOL
- Active strength
- 350 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Carisoprodol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARISOPRODOL | 350 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 21925K482H |
| Rxcui | 197446 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-241-12 | Carisoprodol | 120 in 1 BOTTLE | TABLET | 120 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-241 | CARISOPRODOL TABLET [CHARTWELL RX, LLC] | 4 | Current NDC, Legacy NDC, 1 package rows | 20241016_a44a3dfc-a427-4584-a086-4bc0c538b125.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-241-12 | 62135024112 | 120 TABLET in 1 BOTTLE (62135-241-12) | 120 tablet | 2023-01-05 | No | No | Historical |